Adimmune gets green light to start human trials of COVID-19 vaccine
08/20/2020 05:49 PM
An experimental COVID-19 vaccine developed by Taiwanese maker Adimmune Corp. has been given the green light to start human trials, making it the first in the country to receive approval, Taiwan's Food and Drug Administration (FDA) said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan's inclusion on U.S. currency monitoring list 'could become routine'
11/16/2024 06:10 PM - Society
Police hunt for suspect in High Speed Rail dagger incident
11/16/2024 04:46 PM - Sports
- Politics
IC cooperation with Lithuania continues despite factory construction halt
11/16/2024 02:53 PM - Society
Usagi downgraded to tropical depression, warnings lifted
11/16/2024 01:05 PM